Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
ASSETS    
Cash $ 1,793,672 $ 2,444,148
Prepaid expenses 335,276 379,443
Total Current Assets 2,128,948 2,823,591
Investments held in trust account 345,041,665 345,013,507
Total Assets 347,170,613 347,837,098
LIABILITIES AND STOCKHOLDERS’ EQUITY    
Accounts payable 0 142,290
Franchise tax payable 50,000 185,753
Accrued expenses 141,431 69,090
Total Current Liabilities 191,431 397,133
Derivative warrant liabilities 6,654,367 10,087,466
Deferred underwriter commissions in connection with initial public offering 10,675,000 10,675,000
Total Liabilities 17,520,798 21,159,599
Common stock subject to possible redemption 345,000,000 345,000,000
Preferred stock 0 0
Accumulated deficit (15,351,157) (18,323,473)
Total Stockholders’ Deficit (15,350,185) (18,322,501)
Total Liabilities and Stockholders’ Deficit 347,170,613 347,837,098
Series A common stock    
Common stock 109 109
Series B common stock    
Common stock 0 0
Series C common stock    
Common stock 0 0
Series F common stock    
Common stock $ 863 $ 863